跳转至内容
Merck
CN

SML0934

Enfuvirtide acetate salt

≥95% (HPLC), HIV fusion inhibitor , powder

别名:

T-20 acetate salt

登录 查看组织和合同定价。

选择尺寸


关于此项目

经验公式(希尔记法):
C204H301N51O64 · xC2H4O2
化学文摘社编号:
分子量:
4491.88 (free base basis)
UNSPSC Code:
51111800
NACRES:
NA.77
Assay:
≥95% (HPLC)
Form:
powder
Quality level:
Storage condition:
desiccated, protect from light
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

Enfuvirtide acetate salt, ≥95% (HPLC)

assay

≥95% (HPLC)

form

powder

storage condition

desiccated, protect from light

color

white to off-white

shipped in

wet ice

storage temp.

−20°C

Quality Level

General description

Enfuvirtide acetate salt is a linear synthetic peptide made of 36 amino acids. It has an acetylated N-terminus and a carboxamide C-terminus. Enfuvirtide is catabolized with the help of proteolytic enzymes.

Biochem/physiol Actions

Enfuvirtide is an HIV fusion inhibitor used to patients with multi-drug resistant HIV. Enfuvirtide binds to gp41 preventing the creation of an entry pore for the HIV-1 virus.
Enfuvirtide is an HIV fusion inhibitor.

Other Notes

Light sensitive

存储类别

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

法规信息

常规特殊物品
此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Desk Encyclopedia of Microbiology (2010)
Alexander Herrmann et al.
Scientific reports, 10(1), 1326-1326 (2020-01-30)
Overcoming the global health threat of HIV infection requires continuous pipelines of novel drug candidates. We identified the γ-pyrone polyketides Aureothin/Neoaureothin as potent hits by anti-HIV screening of an extensive natural compound collection. Total synthesis of a structurally diverse group

商品

Bioactive small molecules for immune system signaling target identification/validation and antibiotics, antivirals, and antifungals offered.

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持